Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of plasmodium vivax from Kolkata, India

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 1, 2014, Pages 196-200

  Ganguly, Swagata ^a   Saha, Pabitra ^a   Chatterjee, Moytrey ^a   Maji, Ardhendu K ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; CHLOROQUINE; FOLIC ACID ANTAGONIST; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIFOLATE DRUG RESISTANCE; ARTICLE; DIAGNOSTIC ERROR; DNA SEQUENCE; DRUG EFFECT; DRUG RESISTANCE; GENE MUTATION; HAPLOTYPE; INDIA; MALARIA FALCIPARUM; MARKER GENE; MICROBIAL GENE; MIXED INFECTION; NONHUMAN; PARASITE ISOLATION; PLASMODIUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; PVDHFR GENE; PVDHPS GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION;

ANTIMALARIALS; ARTEMISININS; FOLIC ACID ANTAGONISTS; HAPLOTYPES; INDIA; MALARIA, VIVAX; MUTATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PYRIMETHAMINE; SULFADOXINE;

EID: 84891533930     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01171-13     Document Type: Article

References (34)

1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. 2007. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77:79 - 87.
2. Gething PW, Elyazar IRF, Moyes CM, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HFL, Price RN, Mueller I, Baird JK, Hay SI. 2012. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl. Trop. Dis. 6:e1814. http://dx.doi.org/10.1371/journal.pntd.0001814.
3. Battle KE, Gething WG, Elyazar IRF, Moyes CL, Sinka ME, Howes RE, Guerra CA, Price RN, Baird JK, Hay SI. 2012. The global public health significance of Plasmodium vivax. Adv. Parasitol. 80:1-94. http://dx.doi.org/10.1016/B978-0-12- 397900-1.00001-3.
4. Young MD, Burgess RW. 1959. Pyrimethamine resistance in Plasmodium vivax malaria. Bull. World Health Org. 20:27-36.
5. Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkenberg E, Whitty CJ, Rowland M. 2007. Sulfadoxine-pyrimethamine, chlorproguanildapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. JAMA 297: 2201-2209. http://dx.doi.org/10.1001/ jama.297.20.2201.
6. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV. 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanildapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185: 380-388. http://dx.doi.org/10.1086/ 338566.
7. Basco LK, Tahar R, Ringwald P. 1998. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrob. Agents Chemother. 42:1811-1814.
8. Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM. 2005. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop. 95:183-193. http://dx.doi.org/10.1016/j.actatropica.2005.06.015.
9. Triglia T, Menting JG, Wilson C, Cowman AF. 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 94:13944-13949. http://dx.doi.org/10.1073/pnas.94.25.13944.
10. Vinayak S, Alam MT, Mixson-Hayden T, McCollum AM, Sem R, Shah NK, Lim P, Muth S, Rogers WO, Fandeur T, Barnwell JW, Escalante AA, Wongsrichanalai C, Ariey F, Meshnick SR, Udhayakumar V. 2010. Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum. PLoS Pathog. 6:e1000830. http://dx.doi.org/10. 1371/journal.ppat.1000830.
11. Eldin de Pecoulas P, Basco LK, Tahar R, Ouatas T, Mazabraud A. 1998. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequences. Gene 211:177-185. http://dx.doi.org/10.1016/S0378-1119(98)00118- 8.
12. Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF. 1998. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 17:3807-3815. http://dx.doi.org/10.1093/emboj/17.14.3807.
13. Triglia T, Cowman AF. 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 91:7149-7153. http://dx.doi.org/10.1073/pnas.91.15.7149.
14. Imwong M, Pukrittayakamee S, Renia L, Letourneur F, Charlieu JP, Leartsakulpanich U, Looareesuwan S, White NJ, Snounou G. 2003. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob. Agents Chemother. 47:1514-1521. http://dx.doi.org/10.1128/AAC.47.5.1514-1521.2003.
15. Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, Ménard D. 2008. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob. Agents Chemother. 52:4233-4240. http://dx.doi.org/10.1128/AAC.00578-08.
16. Imwong M, Pukrittayakamee S, Cheng Q, Moore C, Looareesuwan S, Snounou G, White NJ, Day NP. 2005. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob. Agents. Chemother. 49:4393-4395. http://dx.doi.org/10.1128/AAC.49.10.4393-4395.2005.
17. Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirriez J, White NJ, Snounou G. 2001. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45: 3122-3127. http://dx.doi.org/10. 1128/AAC.45.11.3122-3127.2001.
18. Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH. 2007. Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol. 23:213-222. http://dx.doi.org/10.1016/j.pt.2007.03.002.
19. Kaur S, Prajapati SK, Kalyanaraman K, Mohmmed A, Joshi H, Chauhan VS. 2006. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. Acta Trop. 97:174-180. http://dx.doi.org/10.1016/j.actatropica. 2005.10.003.
20. Valecha N, Joshi H, Eapen A, Ravinderan J, Kumar A, Prajapati SK, Ringwald P. 2006. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their pvdhfr gene mutation pattern. Trans. R. Soc. Trop. Med. Hyg. 100:831-837. http://dx.doi.org/10.1016/j.trstmh.2005.11.012.
21. Prajapati SK, Joshi H, Dev V, Dua VK. 2011. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India. Malar. J. 10:102. http://dx.doi.org/10.1186/1475-2875-10-102.
22. Alam MT, Bora H, Bharti PK, Saifi MA, Das MK, Dev Kumar VA, Singh N, Dash AP, Das B, Wajihullah, Sharma YD. 2007. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents. Chemother. 51:857-863. http://dx.doi.org/10.1128/AAC.01200- 06.
23. World Health Organization. 2009. Methods for surveillance of antimalarial drug efficacy. World Health Organization, Geneva, Switzerland.
24. Ganguly S, Saha P, Guha SK, Das S, Bera DK, Biswas A, Kundu PK, Saha B, Ray K, Maji AK. 2013. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine in vivax malaria in Kolkata, West Bengal, India and polymorphism in pvmdr1 and pvcrt-o genes. Antimicrob. Agents. Chemother. 57:1246-1251. http://dx.doi.org/10.1128/AAC.02050-12.
25. Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B. 2008. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxinepyrimethamine: mutations in pvdhfr and pvmdr1. J. Infect. Dis. 198:409-417. http://dx.doi.org/10.1086/589882.
26. Sá JM, Nomura T, Neves J, Baird JK, Wellems TE, del Portillo HA. 2005. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp. Parasitol. 109:256-259. http://dx.doi.org/10.1016/j.exppara.2004. 12.005.
27. Hastings MD, Maguire JD, Bangs MJ, Zimmerman PA, Reeder JC, Baird JK, Sibley CH. 2005. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. Antimicrob. Agents Chemother. 49:733-740. http://dx.doi.org/10.1128/AAC.49.2.733-740.2005.
28. Hastings MD, Porter KM, Maguire JD, Susanti I, Kania W, Bangs MJ, Sibley CH, Baird JK. 2004. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J. Infect. Dis. 189:744-750. http://dx.doi.org/10.1086/381397.
29. Rungsihirunrat K, Na-Bangchang K, Hawkins VN, Mungthin M, Sibley CH. 2007. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand. Am. J. Trop. Med. Hyg. 76:1057-1065.
30. Brega S, de Monbrison F, Severini C, Udomsangpetch R, Sutanto I, Ruckert P, Peyron F, Picot S. 2004. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob. Agents Chemother. 48:2581-2587. http://dx.doi.org/10.1128/AAC.48.7.2581-2587.2004.
31. Korsinczky M, Fischer K, Chen N, Baker J, Rieckmann K, Cheng Q. 2004. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxinebinding site. Antimicrob. Agents Chemother. 48:2214-2222. http://dx.doi.org/10.1128/AAC.48.6. 2214-2222.2004.
32. Lu F, Lim CS, Nam DH, Kim K, Lin K, Kim TS, Lee HW, Chen JH, Wang Y, Sattabongkot J, Han ET. 2010. Mutations in the antifolateresistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries. Am. J. Trop. Med. Hyg. 83:474-479. http://dx.doi.org/10.4269/ajtmh.2010.10-0004.
33. Rungsihirunrat K, Sibley CH, Mungthin M, Na-Bangchang K. 2008. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand. Am. J. Trop. Med. Hyg. 78:462-467.
34. Saha P, Guha SK, Das S, Mullick S, Ganguly S, Biswas A, Bera DK, Chattopadhyay G, Das M, Kundu PK, Ray K, Maji AK. 2012. Comparative efficacy of artemisinin combination therapies (ACTs) in P. falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr and pfdhps genes in tea gardens of Jalpaiguri district, India. Antimicrob. Agents Chemother. 56:2511-2517. http://dx.doi.org/10.1128/AAC.05388-11.